Alfa Chemistry Materials 3 - Products
Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
| Product | Description | |
|---|---|---|
| mPEG5K-Alkyne | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: mPEG-Alkyne, Methoxy-PEG-Alkyne. Mole weight: average Mn 5000. |  |
| mPEG5K-Hydrazide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: Methoxy-PEG-HZ, mPEG-Hydrazide. Mole weight: average Mn 5000. | |
| mPEG5K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: mPEG-Isocyanate. Mole weight: average Mn 5000. | |
| mPEG5K-Phosphate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Mole weight: average Mn 5000. | |
| mPEG5K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Mole weight: average Mn 5000. | |
| mPEG5K-Silane | Methoxy PEG silanes are used for surface modification and deactivation of glass or silica. Alternative Names: mPEG-Silane. Mole weight: average Mn 5,000. | |
| mPEG5-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C11H25NO5. Mole weight: 251.32g/mol. IUPAC Name: 2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethanamine. SMILES: COCCOCCOCCOCCOCCN. InChI: InChI=1S/C11H25NO5/c1-13-4-5-15-8-9-17-11-10-16-7-6-14-3-2-12/h2-12H2,1H3. | |
| mPEG5-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C11H24O6. Mole weight: 252.3g/mol. IUPAC Name: 2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethanol. SMILES: COCCOCCOCCOCCOCCO. InChI: InChI=1S/C11H24O6/c1-13-4-5-15-8-9-17-11-10-16-7-6-14-3-2-12/h12H,2-11H2,1H3. | |
| mPEG5-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C11H24O5S. Mole weight: 268.37g/mol. IUPAC Name: 2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethanethiol. SMILES: COCCOCCOCCOCCOCCS. InChI: InChI=1S/C11H24O5S/c1-12-2-3-13-4-5-14-6-7-15-8-9-16-10-11-17/h17H,2-11H2,1H3. | |
| mPEG6-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. | |
| mPEG6-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C13H28N3O6+. Mole weight: average Mn 6000. IUPAC Name: imino-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethylimino]azanium. SMILES: COCCOCCOCCOCCOCCOCCN=[N+]=N. InChI: InChI=1S/C13H28N3O6/c1-17-4-5-19-8-9-21-12-13-22-11-10-20-7-6-18-3-2-15-16-14/h14H,2-13H2,1H3/q+1. | |
| mPEG6-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C13H29NO6. Mole weight: 295.37g/mol. IUPAC Name: 2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanamine. SMILES: COCCOCCOCCOCCOCCOCCN. InChI: InChI=1S/C13H29NO6/c1-15-4-5-17-8-9-19-12-13-20-11-10-18-7-6-16-3-2-14/h2-14H2,1H3. | |
| mPEG6-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: Methoxy-PEG6-Hydroxyl. Molecular formula: C13H28O7. Mole weight: 296.36g/mol. IUPAC Name: 2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol. SMILES: [H]OCCOC. InChI: 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. | |
| mPEG6-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C16H32O9. Mole weight: 368.42g/mol. IUPAC Name: 3-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid. SMILES: COCCOCCOCCOCCOCCOCCOCCC(=O)O. InChI: InChI=1S/C16H32O9/c1-19-4-5-21-8-9-23-12-13-25-15-14-24-11-10-22-7-6-20-3-2-16(17)18/h2-15H2,1H3,(H,17,18). | |
| mPEG6-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C13H28O6S. Mole weight: 312.42g/mol. IUPAC Name: 2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanethiol. SMILES: COCCOCCOCCOCCOCCOCCS. InChI: InChI=1S/C13H28O6S/c1-14-2-3-15-4-5-16-6-7-17-8-9-18-10-11-19-12-13-20/h20H,2-13H2,1H3. | |
| mPEG7-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. | |
| mPEG7-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Mole weight: average Mn 7000. | |
| mPEG7-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C15H33NO7. Mole weight: 339.42g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine. SMILES: COCCOCCOCCOCCOCCOCCOCCN. InChI: InChI=1S/C15H33NO7/c1-17-4-5-19-8-9-21-12-13-23-15-14-22-11-10-20-7-6-18-3-2-16/h2-16H2,1H3. | |
| mPEG7-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: Methoxy-PEG7-Hydroxyl. Molecular formula: C15H32O8. Mole weight: 340.41g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol. SMILES: [H]OCCOC. InChI: 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. | |
| mPEG7-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C18H36O10. Mole weight: 412.5g/mol. IUPAC Name: 3-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid. SMILES: COCCOCCOCCOCCOCCOCCOCCOCCC(=O)O. InChI: InChI=1S/C18H36O10/c1-21-4-5-23-8-9-25-12-13-27-16-17-28-15-14-26-11-10-24-7-6-22-3-2-18(19)20/h2-17H2,1H3,(H,19,20). | |
| mPEG7-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Molecular formula: C15H32O7S. Mole weight: 356.5g/mol. IUPAC Name: 2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanethiol. SMILES: COCCOCCOCCOCCOCCOCCOCCS. InChI: InChI=1S/C15H32O7S/c1-16-2-3-17-4-5-18-6-7-19-8-9-20-10-11-21-12-13-22-14-15-23/h23H,2-15H2,1H3. | |
| Mpeg bromoisobutyrate | Mpeg bromoisobutyrate. Alternative Names: ATRP initiator;mPEG bromoisobutyrate;PEG methyl ether bromoisobutyrate;Poly(ethylene glycol) methyl ether 2-bromoisobutyrate;mPEG bromoisobutyrate 1000;PEG methyl ether bromoisobutyrate 1000;methoxyPolyethylene glycol bromoisobutyryl;mPEG ATRP. CAS No. 245070-97-7. | |
| m-Tolylboronic acid MIDA ester | m-Tolylboronic acid MIDA ester. | |
| Mytilus edulis foot protein-1 | Mytilus edulis foot protein-1 is one of several proteins in the byssal adhesive plaque of the mussel M. edulis. The high content of 3,4-dihydroxyphenylalanine and its localization near the plaque-substrate interface have often prompted speculation that Mefp plays a key role in adhesion. Alternative Names: MEFP-1. | |
| N1-(3-Trimethoxysilylpropyl)diethylenetriamine | Liquid. CAS No. 35141-30-1. Molecular formula: C10H27N3O3Si. Mole weight: 265.43g/mol. IUPAC Name: N'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine. SMILES: CO[Si](CCCNCCNCCN)(OC)OC. InChI: InChI=1S/C10H27N3O3Si/c1-14-17(15-2,16-3)10-4-6-12-8-9-13-7-5-11/h12-13H,4-11H2,1-3H3. | |
| N-(2-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)pivalamide | N-(2-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)pivalamide. Molecular formula: C16H24BBrN2O3. Mole weight: 383.1g/mol. IUPAC Name: N-[2-bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-2,2-dimethylpropanamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=C(N=C2)Br)NC(=O)C(C)(C)C. InChI: InChI=1S/C16H24BBrN2O3/c1-14(2,3)13(21)20-11-8-10(9-19-12(11)18)17-22-15(4,5)16(6,7)23-17/h8-9H,1-7H3,(H,20,21). | |
| N-(2-Bromo-5-((tert-butyldimethylsilyloxy)methyl)pyridin-3-yl)pivalamide | N-(2-Bromo-5-((tert-butyldimethylsilyloxy)methyl)pyridin-3-yl)pivalamide. Molecular formula: C17H29BrN2O2Si. Mole weight: 401.4g/mol. IUPAC Name: N-[2-bromo-5-[[tert-butyl(dimethyl)silyl]oxymethyl]pyridin-3-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(N=CC(=C1)CO[Si](C)(C)C(C)(C)C)Br. InChI: InChI=1S/C17H29BrN2O2Si/c1-16(2,3)15(21)20-13-9-12(10-19-14(13)18)11-22-23(7,8)17(4,5)6/h9-10H,11H2,1-8H3,(H,20,21). | |
| N-(2-Chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)pivalamide | N-(2-Chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)pivalamide. Molecular formula: C16H24BClN2O3. Mole weight: 338.6g/mol. IUPAC Name: N-[2-chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-2,2-dimethylpropanamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=NC(=C(C=C2)NC(=O)C(C)(C)C)Cl. InChI: InChI=1S/C16H24BClN2O3/c1-14(2,3)13(21)19-10-8-9-11(20-12(10)18)17-22-15(4,5)16(6,7)23-17/h8-9H,1-7H3,(H,19,21). | |
| N-(2-Chloro-6-iodo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)pivalamide | N-(2-Chloro-6-iodo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)pivalamide. Molecular formula: C16H23BClIN2O3. Mole weight: 464.5g/mol. IUPAC Name: N-[2-chloro-6-iodo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-2,2-dimethylpropanamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=NC(=C2NC(=O)C(C)(C)C)Cl)I. InChI: InChI=1S/C16H23BClIN2O3/c1-14(2,3)13(22)21-11-9(8-10(19)20-12(11)18)17-23-15(4,5)16(6,7)24-17/h8H,1-7H3,(H,21,22). | |
| N-(2-Chloro-6-iodo-4-(trimethylsilyl)pyridin-3-yl)pivalamide | N-(2-Chloro-6-iodo-4-(trimethylsilyl)pyridin-3-yl)pivalamide. Molecular formula: C13H20ClIN2OSi. Mole weight: 410.75g/mol. IUPAC Name: N-(2-chloro-6-iodo-4-trimethylsilylpyridin-3-yl)-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(N=C(C=C1[Si](C)(C)C)I)Cl. InChI: InChI=1S/C13H20ClIN2OSi/c1-13(2,3)12(18)17-10-8(19(4,5)6)7-9(15)16-11(10)14/h7H,1-6H3,(H,17,18). | |
| N-(2-Chloro-6-((Trimethylsilyl)Ethynyl)Pyridin-3-Yl)Pivalamide | N-(2-Chloro-6-((Trimethylsilyl)Ethynyl)Pyridin-3-Yl)Pivalamide. CAS No. 1142191-97-6. Molecular formula: C15H21ClN2OSi. Mole weight: 308.88g/mol. Purity: 0.95. IUPAC Name: N-[2-chloro-6-(2-trimethylsilylethynyl)pyridin-3-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(N=C(C=C1)C#C[Si](C)(C)C)Cl. InChI: InChI=1S/C15H21ClN2OSi/c1-15(2,3)14(19)18-12-8-7-11(17-13(12)16)9-10-20(4,5)6/h7-8H,1-6H3,(H,18,19). | |
| N-(2-Chloro-6-(trimethylsilyl)pyridin-3-yl)-pivalamide | N-(2-Chloro-6-(trimethylsilyl)pyridin-3-yl)-pivalamide. Alternative Names: N-(2-CHLORO-6-(TRIMETHYLSILYL)PYRIDIN-3-YL)-PIVALAMIDE, N-(2-Chloro-6-(trimethylsilyl)pyridin-3-yl)pivalamide, 1142191-74-9, AC1Q1LOD, CTK7F3822, AKOS015851208, AG-B-31606, AK-56790, A-6021, N-[2-chloro-6-(trimethylsilyl)pyridin-3-yl]-2,2-dimethylpropanamide. CAS No. 1142191-74-9. Molecular formula: C13H21ClN2OSi. Mole weight: 284.86. Purity: 96%. IUPAC Name: N-(2-chloro-6-trimethylsilylpyridin-3-yl)-2,2-dimethylpropanamide. | |
| N-(2-dimethylaminoethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | N-(2-dimethylaminoethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide. Molecular formula: C17H27BN2O3. Mole weight: 318.2g/mol. IUPAC Name: N-[2-(dimethylamino)ethyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC=C2)C(=O)NCCN(C)C. InChI: InChI=1S/C17H27BN2O3/c1-16(2)17(3,4)23-18(22-16)14-9-7-8-13(12-14)15(21)19-10-11-20(5)6/h7-9,12H,10-11H2,1-6H3,(H,19,21). | |
| N-(2-dimethylaminoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | N-(2-dimethylaminoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide. Molecular formula: C17H27BN2O3. Mole weight: 318.2g/mol. IUPAC Name: N-[2-(dimethylamino)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)C(=O)NCCN(C)C. InChI: InChI=1S/C17H27BN2O3/c1-16(2)17(3,4)23-18(22-16)14-9-7-13(8-10-14)15(21)19-11-12-20(5)6/h7-10H,11-12H2,1-6H3,(H,19,21). | |
| N-[2-hydroxyethyl]benzamide-3-boronic acid, pinacol ester | N-[2-hydroxyethyl]benzamide-3-boronic acid, pinacol ester. Molecular formula: C15H22BNO4. Mole weight: 291.15g/mol. IUPAC Name: N-(2-hydroxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC=C2)C(=O)NCCO. InChI: InChI=1S/C15H22BNO4/c1-14(2)15(3,4)21-16(20-14)12-7-5-6-11(10-12)13(19)17-8-9-18/h5-7,10,18H,8-9H2,1-4H3,(H,17,19). | |
| N-(2-Methoxy-4-(trimethylsilyl)pyridin-3-yl)pivalamide | N-(2-Methoxy-4-(trimethylsilyl)pyridin-3-yl)pivalamide. Molecular formula: C14H24N2O2Si. Mole weight: 280.44g/mol. IUPAC Name: N-(2-methoxy-4-trimethylsilylpyridin-3-yl)-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(C=CN=C1OC)[Si](C)(C)C. InChI: InChI=1S/C14H24N2O2Si/c1-14(2,3)13(17)16-11-10(19(5,6)7)8-9-15-12(11)18-4/h8-9H,1-7H3,(H,16,17). | |
| N-(3-((3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)methyl)-2-chloropyridin-4-yl)pivalamide | N-(3-((3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)methyl)-2-chloropyridin-4-yl)pivalamide. CAS No. 1186310-83-7. Molecular formula: C22H38ClN3O2Si. Mole weight: 440.1g/mol. IUPAC Name: N-[3-[[3-[[tert-butyl(dimethyl)silyl]oxymethyl]pyrrolidin-1-yl]methyl]-2-chloropyridin-4-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(C(=NC=C1)Cl)CN2CCC(C2)CO[Si](C)(C)C(C)(C)C. InChI: InChI=1S/C22H38ClN3O2Si/c1-21(2,3)20(27)25-18-9-11-24-19(23)17(18)14-26-12-10-16(13-26)15-28-29(7,8)22(4,5)6/h9,11,16H,10,12-15H2,1-8H3,(H,24,25,27). | |
| N-(3-(3-(tert-Butyldimethylsilyloxy)propyl)pyridin-2-yl)pivalamide | N-(3-(3-(tert-Butyldimethylsilyloxy)propyl)pyridin-2-yl)pivalamide. Molecular formula: C19H34N2O2Si. Mole weight: 350.6g/mol. IUPAC Name: N-[3-[3-[tert-butyl(dimethyl)silyl]oxypropyl]pyridin-2-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(C=CC=N1)CCCO[Si](C)(C)C(C)(C)C. InChI: InChI=1S/C19H34N2O2Si/c1-18(2,3)17(22)21-16-15(11-9-13-20-16)12-10-14-23-24(7,8)19(4,5)6/h9,11,13H,10,12,14H2,1-8H3,(H,20,21,22). | |
| N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)pyridin-2-yl)pivalamide | N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)pyridin-2-yl)pivalamide. Molecular formula: C17H24BF3N2O3. Mole weight: 372.2g/mol. IUPAC Name: 2,2-dimethyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)pyridin-2-yl]propanamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2NC(=O)C(C)(C)C)C(F)(F)F. InChI: InChI=1S/C17H24BF3N2O3/c1-14(2,3)13(24)23-12-11(8-10(9-22-12)17(19,20)21)18-25-15(4,5)16(6,7)26-18/h8-9H,1-7H3,(H,22,23,24). | |
| N3-PEG3500-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: N3-PEG-NH2. Mole weight: average Mn 3,500. | |
| N3-PEG3500-NHS | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: N3-PEG-NHS, Azide-PEG-NHS, N3-PEG-NHS. Mole weight: average Mn 3,500. | |
| N3-PEG5K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: N3-PEG-NH2. Mole weight: average Mn 5000. | |
| N3-PEG5K-NHS | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Alternative Names: N3-PEG-NHS, Azide-PEG-NHS, N3-PEG-NHS. Mole weight: average Mn 5000. | |
| N-[3-(Trimethoxysilyl)propyl]-N'-(4-vinylbenzyl)ethylenediamine hydrochloride solution | N-[3-(Trimethoxysilyl)propyl]-N'-(4-vinylbenzyl)ethylenediamine hydrochloride solution. CAS No. 33401-49-9. Molecular formula: H2C=CHC6H4CH2NHCH2CH2NH(CH2)3Si(OCH3)3·HCl. Mole weight: 374.98. IUPAC Name: N'-[(4-ethenylphenyl)methyl]-N-(3-trimethoxysilylpropyl)ethane-1,2-diamine;hydrochloride. SMILES: Cl.CO[Si](CCCNCCNCc1ccc(C=C)cc1)(OC)OC. InChI: 1S/C17H30N2O3Si.ClH/c1-5-16-7-9-17(10-8-16)15-19-13-12-18-11-6-14-23(20-2,21-3)22-4;/h5,7-10,18-19H,1,6,11-15H2,2-4H3;1H. | |
| N-(4-Hydroxy-5-((Trimethylsilyl)Ethynyl)Pyridin-3-Yl)Acetamide | N-(4-Hydroxy-5-((Trimethylsilyl)Ethynyl)Pyridin-3-Yl)Acetamide. CAS No. 1203499-31-3. Molecular formula: C12H16N2O2Si. Mole weight: 248.35g/mol. Purity: 0.95. IUPAC Name: N-[4-oxo-5-(2-trimethylsilylethynyl)-1H-pyridin-3-yl]acetamide. SMILES: CC(=O)NC1=CNC=C(C1=O)C#C[Si](C)(C)C. InChI: InChI=1S/C12H16N2O2Si/c1-9(15)14-11-8-13-7-10(12(11)16)5-6-17(2,3)4/h7-8H,1-4H3,(H,13,16)(H,14,15). | |
| N-(4-phenylboronic)succinamic acid | N-(4-phenylboronic)succinamic acid. Alternative Names: 4-Succinamidophenylboronic acid, 578754_ALDRICH, BM085, N-(4-Phenylboronic)succinamic acid, 480424-95-1. CAS No. 480424-95-1. Molecular formula: C10H12BNO5. Mole weight: 237.02. Purity: 96%. IUPAC Name: 4-(4-boronoanilino)-4-oxobutanoic acid. SMILES: B(C1=CC=C(C=C1)NC(=O)CCC(=O)O)(O)O. | |
| N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)acetamide | N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)acetamide. Molecular formula: C13H19BN2O3. Mole weight: 262.11g/mol. IUPAC Name: N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]acetamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2)NC(=O)C. InChI: InChI=1S/C13H19BN2O3/c1-9(17)16-11-6-10(7-15-8-11)14-18-12(2,3)13(4,5)19-14/h6-8H,1-5H3,(H,16,17). | |
| N-(5-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pivalamide | N-(5-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pivalamide. Molecular formula: C16H24BFN2O3. Mole weight: 322.2g/mol. IUPAC Name: N-[5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]-2,2-dimethylpropanamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2NC(=O)C(C)(C)C)F. InChI: InChI=1S/C16H24BFN2O3/c1-14(2,3)13(21)20-12-11(8-10(18)9-19-12)17-22-15(4,5)16(6,7)23-17/h8-9H,1-7H3,(H,19,20,21). | |
| N-(5-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pivalamide | N-(5-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pivalamide. CAS No. 1310383-24-4. Molecular formula: C17H27BN2O3. Mole weight: 318.2g/mol. IUPAC Name: 2,2-dimethyl-N-[5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]propanamide. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2NC(=O)C(C)(C)C)C. InChI: InChI=1S/C17H27BN2O3/c1-11-9-12(18-22-16(5,6)17(7,8)23-18)13(19-10-11)20-14(21)15(2,3)4/h9-10H,1-8H3,(H,19,20,21). | |
| N-(6-((3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)methyl)-2-chloropyridin-3-yl)pivalamide | N-(6-((3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)methyl)-2-chloropyridin-3-yl)pivalamide. Molecular formula: C22H38ClN3O2Si. Mole weight: 440.1g/mol. IUPAC Name: N-[6-[[3-[[tert-butyl(dimethyl)silyl]oxymethyl]pyrrolidin-1-yl]methyl]-2-chloropyridin-3-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(N=C(C=C1)CN2CCC(C2)CO[Si](C)(C)C(C)(C)C)Cl. InChI: InChI=1S/C22H38ClN3O2Si/c1-21(2,3)20(27)25-18-10-9-17(24-19(18)23)14-26-12-11-16(13-26)15-28-29(7,8)22(4,5)6/h9-10,16H,11-15H2,1-8H3,(H,25,27). | |
| N-(6-Bromo-2-((tert-butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-7-yl)pivalamide | N-(6-Bromo-2-((tert-butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-7-yl)pivalamide. Molecular formula: C19H29BrN2O3Si. Mole weight: 441.4g/mol. IUPAC Name: N-[6-bromo-2-[[tert-butyl(dimethyl)silyl]oxymethyl]furo[3,2-b]pyridin-7-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C2C(=NC=C1Br)C=C(O2)CO[Si](C)(C)C(C)(C)C. InChI: InChI=1S/C19H29BrN2O3Si/c1-18(2,3)17(23)22-15-13(20)10-21-14-9-12(25-16(14)15)11-24-26(7,8)19(4,5)6/h9-10H,11H2,1-8H3,(H,21,22,23). | |
| N-(6-Iodo-2-(Trimethylsilyl)Furo[3,2-B]Pyridin-7-Yl)Pivalamide | N-(6-Iodo-2-(Trimethylsilyl)Furo[3,2-B]Pyridin-7-Yl)Pivalamide. CAS No. 1186310-88-2. Molecular formula: C15H21IN2O2Si. Mole weight: 416.33g/mol. Purity: 0.95. IUPAC Name: N-(6-iodo-2-trimethylsilylfuro[3,2-b]pyridin-7-yl)-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C2C(=NC=C1I)C=C(O2)[Si](C)(C)C. InChI: InChI=1S/C15H21IN2O2Si/c1-15(2,3)14(19)18-12-9(16)8-17-10-7-11(20-13(10)12)21(4,5)6/h7-8H,1-6H3,(H,17,18,19). | |
| N-(6-((tert-Butyldimethylsilyloxy)methyl)-2-chloropyridin-3-yl)pivalamide | N-(6-((tert-Butyldimethylsilyloxy)methyl)-2-chloropyridin-3-yl)pivalamide. CAS No. 1142191-94-3. Molecular formula: C17H29ClN2O2Si. Mole weight: 357g/mol. IUPAC Name: N-[6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-chloropyridin-3-yl]-2,2-dimethylpropanamide. SMILES: CC(C)(C)C(=O)NC1=C(N=C(C=C1)CO[Si](C)(C)C(C)(C)C)Cl. InChI: InChI=1S/C17H29ClN2O2Si/c1-16(2,3)15(21)20-13-10-9-12(19-14(13)18)11-22-23(7,8)17(4,5)6/h9-10H,11H2,1-8H3,(H,20,21). | |
| N-Acetylheparin sodium salt | N-Acetylheparin sodium salt. | |
| N-Acetylneuraminyl-fucosyllacto-N-neo-tetraose from human milk | N-Acetylneuraminyl-fucosyllacto-N-neo-tetraose from human milk. CAS No. 111216-36-5. Molecular formula: C43H72N2O33. Mole weight: 1145g/mol. IUPAC Name: (2R,4S,5R,6R)-5-acetamido-2-[[(2R,3R,4S,5R,6S)-6-[(2R,3S,4R,5R,6S)-5-acetamido-6-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid. SMILES: CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)OC5C(C(C(C(O5)COC6(CC(C(C(O6)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O)O)NC(=O)C)O)CO)O)O)O)O)O. InChI: InChI=1S/C43H72N2O33/c1-10-21(54)26(59)28(61)39(69-10)77-36-30(63)37(65)70-17(8-49)33(36)75-41-31(64)35(24(57)15(6-47)71-41)76-38-20(45-12(3)51)25(58)32(16(7-48)72-38)74-40-29(62)27(60)23(56)18(73-40)9-68-43(42(66)67)4-13(52)19(44-11(2)50)34(78-43)22(55)14(53)5-46/h10,13-41,46-49,52-65H,4-9H2,1-3H3,(H,44,50)(H,45,51)(H,66,67)/t10-,13-,14+,15+,16+,17+,18+,19+,20+,21+,22+,23-,24-,25+,26+,27-,28-,29+,30+,31+,32+,33-,34+,35-,36+,37?,38-,39-,40-,41-,43+/m0/s1. | |
| Nanodiamonds | Nanodiamonds. | |
| Naphthalene-1-boronic acid | Naphthalene-1-boronic acid. CAS No. 13922-41-3. Molecular formula: C10H9BO2. Mole weight: 171.99g/mol. IUPAC Name: naphthalen-1-ylboronic acid. SMILES: B(C1=CC=CC2=CC=CC=C12)(O)O. InChI: InChI=1S/C10H9BO2/c12-11(13)10-7-3-5-8-4-1-2-6-9(8)10/h1-7,12-13H. | |
| N-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine | N-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine. Molecular formula: C18H23BN2O2. Mole weight: 310.2g/mol. IUPAC Name: N-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2)NCC3=CC=CC=C3. InChI: InChI=1S/C18H23BN2O2/c1-17(2)18(3,4)23-19(22-17)15-10-16(13-20-12-15)21-11-14-8-6-5-7-9-14/h5-10,12-13,21H,11H2,1-4H3. | |
| (N-Boc-2-pyrrolyl)dimethylsilanol | (N-Boc-2-pyrrolyl)dimethylsilanol. CAS No. 879904-82-2. Molecular formula: C11H19NO3Si. Mole weight: 241.36g/mol. IUPAC Name: tert-butyl 2-[hydroxy(dimethyl)silyl]pyrrole-1-carboxylate. SMILES: CC(C)(C)OC(=O)N1C=CC=C1[Si](C)(C)O. InChI: InChI=1S/C11H19NO3Si/c1-11(2,3)15-10(13)12-8-6-7-9(12)16(4,5)14/h6-8,14H,1-5H3. | |
| N-Boc-2-trimethylsilyl-1H-pyrrole | N-Boc-2-trimethylsilyl-1H-pyrrole. CAS No. 75400-57-6. | |
| (N-Boc-5-chloro-2-indolyl)boronic acid | (N-Boc-5-chloro-2-indolyl)boronic acid. CAS No. 475102-12-6. Molecular formula: C13H15BClNO4. Mole weight: 295.53g/mol. IUPAC Name: [5-chloro-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid. SMILES: B(C1=CC2=C(N1C(=O)OC(C)(C)C)C=CC(=C2)Cl)(O)O. InChI: InChI=1S/C13H15BClNO4/c1-13(2,3)20-12(17)16-10-5-4-9(15)6-8(10)7-11(16)14(18)19/h4-7,18-19H,1-3H3. | |
| N-Boc-5-methoxy-2-indolylboronic acid | N-Boc-5-methoxy-2-indolylboronic acid. CAS No. 290331-71-4. Molecular formula: C14H18BNO5. Mole weight: 291.11g/mol. IUPAC Name: [5-methoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid. SMILES: B(C1=CC2=C(N1C(=O)OC(C)(C)C)C=CC(=C2)OC)(O)O. InChI: InChI=1S/C14H18BNO5/c1-14(2,3)21-13(17)16-11-6-5-10(20-4)7-9(11)8-12(16)15(18)19/h5-8,18-19H,1-4H3. | |
| N-butyl-3-metylpyridinium bis((trifluoromethyl)sulfonyl)imide | N-butyl-3-metylpyridinium bis((trifluoromethyl)sulfonyl)imide. CAS No. 344790-86-9. Molecular formula: C12H16F6N2O4S2. Mole weight: 430.4g/mol. Purity: ≥99%. IUPAC Name: bis(trifluoromethylsulfonyl)azanide;1-butyl-3-methylpyridin-1-ium. SMILES: CCCC[N+]1=CC=CC(=C1)C.C(F)(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F. InChI: InChI=1S/C10H16N.C2F6NO4S2/c1-3-4-7-11-8-5-6-10(2)9-11;3-1(4,5)14(10,11)9-15(12,13)2(6,7)8/h5-6,8-9H,3-4,7H2,1-2H3;/q+1;-1. | |
| n-Butylammonium Bromide | ≥98%. Alternative Names: 1-Butanamine hydroBromide (1:1), greatcell Solar, Butyl ammonium Bromide, 1-Butanaminium Bromide. CAS No. 15567-09-6. Molecular formula: C4H12BrN. Mole weight: 154.05 g/mol. IUPAC Name: butan-1-amine;hydrobromide. SMILES: CCCCN.Br. InChI: InChI=1S/C4H11N.BrH/c1-2-3-4-5;/h2-5H2,1H3;1H. | |
| n-Butylammonium Iodide | n-Butylammonium Iodide. Alternative Names: 1-Butanaminium Iodide, greatcell Solar, Butylammonium Iodide, Butylamine hydroIodide. CAS No. 36945-08-1. Molecular formula: C4H12IN. Mole weight: 201.05 g/mol. IUPAC Name: butan-1-amine;hydroiodide. SMILES: CCCCN.I. InChI: InChI=1S/C4H11N.HI/c1-2-3-4-5;/h2-5H2,1H3;1H. | |
| n-cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine | n-cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. Molecular formula: C16H25BN2O2. Mole weight: 288.2g/mol. IUPAC Name: N-cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=NC=C2)NC3CCCC3. InChI: InChI=1S/C16H25BN2O2/c1-15(2)16(3,4)21-17(20-15)12-9-10-18-14(11-12)19-13-7-5-6-8-13/h9-11,13H,5-8H2,1-4H3,(H,18,19). | |
| n-cyclopentyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine | n-cyclopentyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine. Molecular formula: C16H25BN2O2. Mole weight: 288.2g/mol. IUPAC Name: N-cyclopentyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CC(=CN=C2)NC3CCCC3. InChI: InChI=1S/C16H25BN2O2/c1-15(2)16(3,4)21-17(20-15)12-9-14(11-18-10-12)19-13-7-5-6-8-13/h9-11,13,19H,5-8H2,1-4H3. | |
| N-cyclopentyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | N-cyclopentyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine. Molecular formula: C15H24BN3O2. Mole weight: 289.18g/mol. IUPAC Name: N-cyclopentyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine. SMILES: B1(OC(C(O1)(C)C)(C)C)C2=CN=C(N=C2)NC3CCCC3. InChI: InChI=1S/C15H24BN3O2/c1-14(2)15(3,4)21-16(20-14)11-9-17-13(18-10-11)19-12-7-5-6-8-12/h9-10,12H,5-8H2,1-4H3,(H,17,18,19). | |
| Neocarradodecaose 41,43,45,47,49,411-hexasulfate hexasodium salt | Neocarradodecaose 41,43,45,47,49,411-hexasulfate hexasodium salt. CAS No. 133628-77-0. Molecular formula: C72H104O73S6Na6. Mole weight: 2467.88. Purity: ≥95%. IUPAC Name: hexasodium;[(2R,3S,4R,5R,6S)-4-[[(1R,3R,4R,5S,8S)-4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-6-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2R,3R,4R,5S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate. SMILES: C1C2C(C(O1)C(C(O2)OC3C(C(OC(C3OS(=O)(=O)[O-])CO)OC4C5COC4C(C(O5)OC6C(C(OC(C6OS(=O)(=O)[O-])CO)OC7C8COC7C(C(O8)OC9C(C(OC(C9OS(=O)(=O)[O-])CO)OC1C2COC1C(C(O2)OC1C(C(OC(C1OS(=O)(=O)[O-])CO)OC1C2COC1C(C(O2)OC1C(C(OC(C1OS(=O)(=O)[O-])CO)OC1C2COC1C(C(O2)OC1C(C(OC(C1OS(=O)(=O)[O-])CO)O)O)O)O)O)O)O)O)O)O)O)O)O)O.[Na+].[Na+].[Na+].[Na+]. | |
| Neocarraoctaose 41,43,45,47-tetrasulfate tetrasodium salt | Neocarraoctaose 41,43,45,47-tetrasulfate tetrasodium salt. CAS No. 133647-94-6. Molecular formula: C48H70Na4O49S4. Mole weight: 1651.3g/mol. IUPAC Name: tetrasodium;[(2R,3S,4R,5R,6S)-4-[[(1R,3R,4R,5S,8S)-4,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-6-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(2S,3R,4R,5S,6R)-2-[[(1R,3R,4R,5R,8S)-3-[(3R,4R,5S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-3-hydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate. SMILES: C1C2C(C(O1)C(C(O2)OC3C(C(OC(C3OS(=O)(=O)[O-])CO)OC4C5COC4C(C(O5)OC6C(C(OC(C6OS(=O)(=O)[O-])CO)OC7C8COC7C(C(O8)OC9C(C(OC(C9OS(=O)(=O)[O-])CO)OC1C2COC1C(C(O2)OC1C(C(OC(C1OS(=O)(=O)[O-])CO)O)O)O)O)O)O)O)O)O)O.[Na+].[Na+].[Na+].[Na+]. InChI: InChI=1S/C48H74O49S4.4Na/c49-1-9-29(94-98(63,64)65)37(18(54)41(62)79-9)90-43-20(56)34-26(14(84-43)6-76-34)87-47-24(60)39(31(11(3-51)81-47)96-100(69,70)71)92-45-22(58)36-28(16(86-45)8-78-36)89-48-25(61)40(32(12(4-52)82-48)97-101(72,73)74)93-44-21(57)35-27(15(85-44)7-77-35)88-46-23(59)38(30(10(2-50)80-46)95-99(66,67)68)91-42-19(55)33-17(53)13(83-42)5-75-33;;;;/h9-62H,1-8H2,(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,7 | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.